NO167865C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 14,17beta-ethano-14beta-oestratrienderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 14,17beta-ethano-14beta-oestratrienderivater.

Info

Publication number
NO167865C
NO167865C NO881688A NO881688A NO167865C NO 167865 C NO167865 C NO 167865C NO 881688 A NO881688 A NO 881688A NO 881688 A NO881688 A NO 881688A NO 167865 C NO167865 C NO 167865C
Authority
NO
Norway
Prior art keywords
ethano
eestrate
14beta
17beta
trends
Prior art date
Application number
NO881688A
Other languages
English (en)
Norwegian (no)
Other versions
NO167865B (no
NO881688D0 (no
NO881688L (no
Inventor
James R Bull
Russel I Thomson
Henry Laurent
Helmut Schroeder
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO881688D0 publication Critical patent/NO881688D0/no
Publication of NO881688L publication Critical patent/NO881688L/no
Priority to NO885112A priority Critical patent/NO168481C/no
Publication of NO167865B publication Critical patent/NO167865B/no
Publication of NO167865C publication Critical patent/NO167865C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO881688A 1986-08-20 1988-04-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive 14,17beta-ethano-14beta-oestratrienderivater. NO167865C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO885112A NO168481C (no) 1986-08-20 1988-11-16 14,17beta-ethano-14beta-oestratrienderivater, befruktningshindrende middel, og anvendelse derav for befruktningskontroll hos kvinner.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863628189 DE3628189A1 (de) 1986-08-20 1986-08-20 Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
PCT/DE1987/000361 WO1988001275A1 (en) 1986-08-20 1987-08-11 14,17beta-ETHANO-14beta-ESTRATRIENES AND ESTRATETRAENES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE

Publications (4)

Publication Number Publication Date
NO881688D0 NO881688D0 (no) 1988-04-19
NO881688L NO881688L (no) 1988-04-19
NO167865B NO167865B (no) 1991-09-09
NO167865C true NO167865C (no) 1991-12-18

Family

ID=6307762

Family Applications (2)

Application Number Title Priority Date Filing Date
NO881688A NO167865C (no) 1986-08-20 1988-04-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive 14,17beta-ethano-14beta-oestratrienderivater.
NO885112A NO168481C (no) 1986-08-20 1988-11-16 14,17beta-ethano-14beta-oestratrienderivater, befruktningshindrende middel, og anvendelse derav for befruktningskontroll hos kvinner.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO885112A NO168481C (no) 1986-08-20 1988-11-16 14,17beta-ethano-14beta-oestratrienderivater, befruktningshindrende middel, og anvendelse derav for befruktningskontroll hos kvinner.

Country Status (22)

Country Link
US (1) US4789671A (ru)
EP (1) EP0318490B1 (ru)
JP (1) JPH02500739A (ru)
KR (1) KR940000167B1 (ru)
CN (1) CN1027270C (ru)
AT (1) ATE72248T1 (ru)
AU (1) AU618939B2 (ru)
CA (1) CA1269102A (ru)
DD (1) DD266801A5 (ru)
DE (2) DE3628189A1 (ru)
DK (1) DK186788D0 (ru)
FI (1) FI94866C (ru)
HU (1) HU203366B (ru)
IE (1) IE60319B1 (ru)
IL (1) IL83302A (ru)
NO (2) NO167865C (ru)
NZ (1) NZ221137A (ru)
PT (1) PT85552B (ru)
RU (1) RU1820910C (ru)
UA (1) UA13378A (ru)
WO (1) WO1988001275A1 (ru)
ZA (1) ZA875359B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838779A1 (de) * 1988-11-11 1990-05-17 Schering Ag 14(alpha),17(alpha)-ethano-estratriene
DE3925507A1 (de) * 1989-07-28 1991-01-31 Schering Ag 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
RU2087479C1 (ru) * 1989-11-29 1997-08-20 Шеринг Аг Эстратриены, содержащие мостик
DE4114634A1 (de) * 1991-04-30 1992-11-05 Schering Ag 14(alpha),17(alpha)-(propano- und 17(pfeil hoch)2(pfeil hoch)-propeno)estratriene
DE4114635A1 (de) * 1991-04-30 1992-11-05 Schering Ag 14(alpha),16(alpha)-ethano-estratriene
DE4222316A1 (de) * 1992-07-03 1994-01-05 Schering Ag Verfahren zur Herstellung von Etheno- und Ethano-16â,17µ-Steroiddiolen und deren Derivaten
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Also Published As

Publication number Publication date
KR880701731A (ko) 1988-11-04
NO168481C (no) 1992-04-01
FI94866C (fi) 1995-11-10
RU1820910C (ru) 1993-06-07
EP0318490A1 (de) 1989-06-07
FI890779A0 (fi) 1989-02-17
HUT50845A (en) 1990-03-28
CN87105736A (zh) 1988-03-09
IL83302A (en) 1991-09-16
AU7757187A (en) 1988-03-08
FI94866B (fi) 1995-07-31
IL83302A0 (en) 1987-12-31
IE872217L (en) 1988-02-20
JPH0515720B2 (ru) 1993-03-02
PT85552A (en) 1987-09-01
DK186788A (da) 1988-04-06
IE60319B1 (en) 1994-06-29
NO167865B (no) 1991-09-09
HU203366B (en) 1991-07-29
NO168481B (no) 1991-11-18
DE3776572D1 (de) 1992-03-12
NO881688D0 (no) 1988-04-19
NZ221137A (en) 1990-09-26
NO881688L (no) 1988-04-19
DE3628189A1 (de) 1988-02-25
JPH02500739A (ja) 1990-03-15
EP0318490B1 (de) 1992-01-29
UA13378A (uk) 1997-02-28
ZA875359B (en) 1988-02-05
NO885112L (no) 1988-04-19
US4789671A (en) 1988-12-06
ATE72248T1 (de) 1992-02-15
FI890779A (fi) 1989-02-17
CN1027270C (zh) 1995-01-04
AU618939B2 (en) 1992-01-16
KR940000167B1 (ko) 1994-01-08
DK186788D0 (da) 1988-04-06
PT85552B (pt) 1990-05-31
CA1269102A (en) 1990-05-15
DD266801A5 (de) 1989-04-12
NO885112D0 (no) 1988-11-16
WO1988001275A1 (en) 1988-02-25

Similar Documents

Publication Publication Date Title
NO149888C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-substituerte-2`-hydroksyl-6,7-benzomorfaner og syreaddisjonssalter derav
PT79735A (de) 11beta-aryl-estradiene deren herstellung und diese enthaltende pharmazeutische praeparate
NO152446C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 9-substituerte hypoxantinderivater
NO883994D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer.
ES2004386A6 (es) Un procedimiento para producir un nuevo derivado de difluorohalometoxifenilo
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
FI850151A0 (fi) 6,6-etylen-15,16-metylen-3-oxo-17 -pregn-4-en-21,17-karbolaktoner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
ES2038623T3 (es) Procedimiento para preparar soluciones de oxazafosforinas con estabilidad mejorada.
NO167865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 14,17beta-ethano-14beta-oestratrienderivater.
DE3762860D1 (de) 2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
GR852867B (ru)
NO823125L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-amino-naftalen-derivater
ATE18211T1 (de) Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.
UA13481A (uk) Спосіб одержання похідних 5-галоідтієноізотіазол-3(2h)-oh-1,1-діоксидів
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
SE8302452D0 (sv) Method for treatment of senile dementia
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media
NO875345D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dibenzo-oksepin derivater.